TBG Diagnostics LimitedCompany Review & Valuation

TDLAF
OTC Markets

About TBG Diagnostics Limited

TBG Diagnostics Limited, a molecular diagnostics company, develops, manufactures, and markets molecular diagnostics kits, assays, instruments, and services in Taiwan, China, and the United States. The company offers nucleic acid extraction, human leukocyte antigen (HLA) sequence specific primer typiShow moreng, HLA sequence based typing, and HPA genotyping kits, as well as reagents and accessories; halotype NGS products; equipment comprising nucleic acid extraction, automated pipetting, and gel electrophoresis systems; and HLA genotyping and contract manufacturing services, as well as reagents analysis software. It serves clinical labs of hospitals and independent reference labs, blood centers, and bone marrow registry labs. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. The company was incorporated in 1989 and is based in Greenslopes, Australia. TBG Diagnostics Limited is a subsidiary of Medigen Biotechnology Corporation.Show less

Industry
Diagnostics & Research
HQ Location
Greenslopes, Australia

Stock Price

Price data not available for TBG Diagnostics Limited.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Sartorius
Danaher
Quest Diagnostics
Cancer Genetics

back to top